DNA Methylation-Based Age Prediction and Telomere Length Reveal an Accelerated Aging in Induced Sputum Cells Compared to Blood Leukocytes: A Pilot Study in COPD Patients

Manuela Campisi, Filippo Liviero, Piero Maestrelli, Gabriella Guarnieri, Sofia Pavanello, Manuela Campisi, Filippo Liviero, Piero Maestrelli, Gabriella Guarnieri, Sofia Pavanello

Abstract

Aging is the predominant risk factor for most degenerative diseases, including chronic obstructive pulmonary disease (COPD). This process is however very heterogeneous. Defining the biological aging of individual tissues may contribute to better assess this risky process. In this study, we examined the biological age of induced sputum (IS) cells, and peripheral blood leukocytes in the same subject, and compared these to assess whether biological aging of blood leukocytes mirrors that of IS cells. Biological aging was assessed in 18 COPD patients (72.4 ± 7.7 years; 50% males). We explored mitotic and non-mitotic aging pathways, using telomere length (TL) and DNA methylation-based age prediction (DNAmAge) and age acceleration (AgeAcc) (i.e., difference between DNAmAge and chronological age). Data on demographics, life style and occupational exposure, lung function, and clinical and blood parameters were collected. DNAmAge (67.4 ± 5.80 vs. 61.6 ± 5.40 years; p = 0.0003), AgeAcc (-4.5 ± 5.02 vs. -10.8 ± 3.50 years; p = 0.0003), and TL attrition (1.05 ± 0.35 vs. 1.48 ± 0.21 T/S; p = 0.0341) are higher in IS cells than in blood leukocytes in the same patients. Blood leukocytes DNAmAge (r = 0.927245; p = 0.0026) and AgeAcc (r = 0.916445; p = 0.0037), but not TL, highly correlate with that of IS cells. Multiple regression analysis shows that both blood leukocytes DNAmAge and AgeAcc decrease (i.e., younger) in patients with FEV1% enhancement (p = 0.0254 and p = 0.0296) and combined inhaled corticosteroid (ICS) therapy (p = 0.0494 and p = 0.0553). In conclusion, new findings from our work reveal a differential aging in the context of COPD, by a direct quantitative comparison of cell aging in the airway with that in the more accessible peripheral blood leukocytes, providing additional knowledge which could offer a potential translation into the disease management.

Keywords: DNA methylation age; age acceleration; chronic obstructive pulmonary disease; induced sputum; lung aging; telomere length.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Campisi, Liviero, Maestrelli, Guarnieri and Pavanello.

Figures

Figure 1
Figure 1
DNAmAge and AgeAcc of the induced sputum cells and blood leukocytes in COPD patients. In (A), box plots show levels of DNAmAge in induced sputum cells (n = 7) and in paired blood leukocytes of the same COPD patient (n = 7), and in blood leukocyte samples of all COPD patients (n = 16). In box plots, the boundary of the box closest to the x-axis indicates the 25th percentile, the line within the box marks the mean, and the boundary of the box farthest from the x-axis indicates the 75th percentile. Whiskers (error bars) above and below the box indicate the 95 and 5th percentiles. The horizontal bar with asterisk indicates the significant comparison between induced sputum cells (n = 7) and paired blood leukocytes DNAmAge of the same patient (n = 7) (*Paired t-test: mean 67.4 ± 5.80 years vs. mean 61.6 ± 5.40 years; p = 0.0003). In contrast, the comparison between the DNAmAge of the induced sputum cells (n = 7) and all blood leukocytes (n = 16) is not significant (Mann–Whitney U-test: mean 67.4 ± 5.80 years vs. mean 63.3 ± 5.60 years; p = 0.1589). In (B), box plots show levels of AgeAcc in induced sputum cells (n = 7) and in paired blood leukocytes of the same COPD patient (n = 7), and in blood leukocytes samples of all COPD patients (n = 16). In box plots, the boundary of the box closest to the x-axis indicates the 25th percentile, the line within the box marks the mean, and the boundary of the box farthest from the x-axis indicates the 75th percentile. Whiskers (error bars) above and below the box indicate the 95th and 5th percentiles. The horizontal bar with an asterisk indicates the significant comparison between induced sputum cells (n = 7) and paired blood leukocytes AgeAcc of the same patient (*Paired t-test (n = 7): mean −4.5 ± 5.02 years vs. mean −10.8 ± 3.50 years; p = 0.0003]. The upper longer horizontal bar with two asterisks indicates the significant comparison between AgeAcc of the induced sputum cells (n = 7) and blood leukocytes in all patients (n = 16) (**Mann–Whitney U-test: mean −4.5 ± 5.02 years vs. mean −10.3 ± 3.63 years; p = 0.0156].
Figure 2
Figure 2
TL of the induced sputum cells and blood leukocytes in COPD patients. Box plots show levels of TL in induced sputum cells (n = 8) and in paired blood leukocytes of the same patient (n = 8), and blood leukocyte samples of all patients (n = 18). In box plots, the boundary of the box closest to the x-axis indicates the 25th percentile, the line within the box marks the mean, and the boundary of the box farthest from the x-axis indicates the 75th percentile. Whiskers (error bars) above and below the box indicate the 95 and 5th percentiles. The horizontal bar with one asterisk indicates the significant comparison between induced sputum cells (n = 8) and paired blood leukocyte TL of the same patient (n = 8) (*Paired t-test: mean 1.05 ± 0.35 T/S vs. mean 1.48 ± 0.21 T/S; p = 0.0341). The upper longer horizontal bar with two asterisks indicates the significant comparison between TL of the induced sputum cells (n = 8) and blood leukocytes in all patients (n = 18) (**MannWhitney U-test: mean 1.05 ± 0.35 T/S vs. mean 1.47 ± 0.26 T/S; p = 0.0133).
Figure 3
Figure 3
Correlation curves between blood leukocytes DNAmAge (A) or AgeAcc (B) and chronological age of n = 16 COPD patients. In (A), a simple linear regression plot shows the correlation between blood leukocyte DNAmAge and chronological age [correlation coefficient (r) = 0.836142; two-sided p < 0.0001], while in (B), simple linear regression linear regression plot showing the correlation between blood leukocyte AgeAcc and chronological age [correlation coefficient (r) = −0.53542; two-sided p = 0.0326]. Mean, standard error (SE), and 95% coefficient intervals (CI) are represented as green, pink, and black lines, respectively.
Figure 4
Figure 4
Correlation curves between blood leukocytes and induced sputum cells DNAmAge (A) or AgeAcc (B) of n = 7 COPD patients. In (A), a simple linear regression plot shows the correlation between blood leukocytes and induced sputum cell DNAmAge [correlation coefficient (r) = 0.927245; two-sided p = 0.0026], whereas in (B), a simple linear regression plot shows the correlation between blood leukocytes and induced sputum cells AgeAcc [correlation coefficient (r) = 0.916445; two-sided p = 0.0037]. Mean, standard error (SE), and 95% coefficient intervals (CI) are represented as green, pink, and black lines, respectively.

References

    1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. (2013) 153:1194–217. 10.1016/j.cell.2013.05.039
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD (2021). Available online at: .
    1. MacNee W, Rabinovich RA, Choudhury G. Ageing and the border between health and disease. Eur Respir. (2014) 44:1332–52. 10.1183/09031936.00134014
    1. Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, et al. . Aging, frailty and age-related diseases. Biogerontology. (2010) 11:547–63. 10.1007/s10522-010-9287-2
    1. Levine ME. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? J Gerontol A Biol Sci Med Sci. (2013) 68:667–74. 10.1093/gerona/gls233
    1. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. . Geroscience: linking aging to chronic disease. Cell. (2014) 159:709–13. 10.1016/j.cell.2014.10.039
    1. Lowe D, Horvath S, Raj K. Epigenetic clock analyses of cellular senescence and ageing. Oncotarget. (2016) 7:8524–31. 10.18632/oncotarget.7383
    1. Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. (2018) 19:371–84. 10.1038/s41576-018-0004-3
    1. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. (2013) 14:R115. 10.1186/gb-2013-14-10-r115
    1. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. . Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. (2013) 49:359–67. 10.1016/j.molcel.2012.10.016
    1. Zbieć-Piekarska R, Spólnicka M, Kupie T, Parys-Proszek A, Makowska Z, Pałeczka A, et al. . Development of a forensically useful age prediction method based on DNA methylation analysis. Forensic Sci Int Genet. (2015) 17:173–9. 10.1016/j.fsigen.2015.05.001
    1. Pavanello S, Campisi M, Tona F, Dal Lin C, Iliceto S. Exploring epigenetic age in response to intensive relaxing training: a pilot study to slow down biological age. Int J Environ Res Public Health. (2019) 16:3074. 10.3390/ijerph16173074
    1. Pavanello S, Campisi M, Fabozzo A, Cibin G, Tarzia V, Toscano G, et al. . The biological age of the heart is consistently younger than chronological age. Sci Rep. (2020) 10:10752. 10.1038/s41598-020-67622-1
    1. Dhingra R, Nwanaji-Enwerem JC, Samet M, Ward-Caviness CK. DNA methylation age—environmental influences, health impacts, and its role in environmental epidemiology. Curr Envir Health Rpt. (2018) 5:317–27. 10.1007/s40572-018-0203-2
    1. Fransquet PD, Wrigglesworth J, Woods RL, Ernst ME, Ryan J. The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. Clin Epig. (2019) 11:62. 10.1186/s13148-019-0656-7
    1. Yoon YS, Jin M, Sin DD. Accelerated lung aging and chronic obstructive pulmonary disease. Expert Rev Respir Med. (2019) 13:369–80. 10.1080/17476348.2019.1580576
    1. Mercado N, Ito K, Barnes PJ. Accelerated aging of the lung in COPD: new concepts. Thorax. (2015) 70:482–9. 10.1136/thoraxjnl-2014-206084
    1. Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, et al. . Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty–a BOLD analysis. Thorax. (2014) 69:465–73. 10.1136/thoraxjnl-2013-204460
    1. Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, et al. . Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. (2014) 2:823–60. 10.1016/S2213-2600(14)70168-7
    1. MacNee W. Is chronic obstructive pulmonary disease an accelerated aging disease? Ann Am Thorac Soc. (2016) 5:S429–37. 10.1513/AnnalsATS.201602-124AW
    1. van Eeden SF, Sin DD. Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process. Can Respir J. (2013) 20:27–9. 10.1155/2013/509130
    1. Li Y, Rittenhouse-Olson K, Scheider WL, Mu L. Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies. Rev Environ Health. (2012) 27:133–49. 10.1515/reveh-2012-0012
    1. Kido T, Tamagawa E, Bai N, Suda K, Yang HH, Li Y, et al. . Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol. (2011) 44:197–204. 10.1165/rcmb.2009-0427OC
    1. Eagan TML, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, et al. . Systemic inflammatory markers in COPD: results from the Bergen COPD cohort study. Eur Resp J. (2010) 35:540–8. 10.1183/09031936.00088209
    1. Pavanello S, Stendardo M, Mastrangelo G, Bonci M, Bottazzi B, Campisi M, et al. . Inflammatory long pentraxin 3 is associated with leukocyte telomere length in night-shift workers. Front Immunol. (2017) 8:516. 10.3389/fimmu.2017.00516
    1. Myte R, Sundkvist A, Van Guelpen B, Harlid S. Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort. Epigenetics. (2019) 14:649–59. 10.1080/15592294.2019.1603962
    1. Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B, et al. . Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2009) 179:566–71. 10.1164/rccm.200809-1398OC
    1. Albrecht E, Sillanpää E, Karrasch S, Alves AC, Codd V, Hovatta I, et al. . Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J. (2014) 43:983–92. 10.1183/09031936.00046213
    1. Breen M, Nwanaji-Enwerem JC, Karrasch S, Flexeder C, Schulz H, Waldenberger M, et al. . Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies. Aging. (2020) 12:16539–54. 10.18632/aging.103784
    1. Weiszhar Z, Horvath I. Induced sputum analysis: step by step. Breathe. (2013) 9:300–6. 10.1183/20734735.042912
    1. Fireman E. Induced sputum and occupational diseases other than asthma. Curr Opin Allergy Clin Immunol. (2009) 9:93–6. 10.1097/ACI.0b013e32832921e0
    1. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. . Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. (2019) 53:1900164. 10.1183/13993003.00164-2019
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. . Standardisation of spirometry. Eur Respir J. (2005) 26:319–38. 10.1183/09031936.05.00034805
    1. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, et al. . Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl. (1993) 16:53–83. 10.1183/09041950.053s1693
    1. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, et al. . Sputum induction. Eur Respir J Suppl. (2002) 37:3s−8s 10.1183/09031936.02.00000302
    1. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax. (1997) 52:498–501. 10.1136/thx.52.6.498
    1. Pavanello S, Angelici L, Hoxha M, Cantone L, Campisi M, Tirelli AS, et al. . Sterol 27-hydroxylase polymorphism significantly associates with shorter telomere, higher cardiovascular and type-2 diabetes risk in obese subjects. Front Endocrinol. (2018) 9:309. 10.3389/fendo.2018.00309
    1. Pavanello S, Campisi M, Mastrangelo G, Hoxha M, Bollati V. The effects of everyday-life exposure to polycyclic aromatic hydrocarbons on biological age indicators. Environ Health. (2020) 19:128. 10.1186/s12940-020-00669-9
    1. Bell CG, Lowe R, Adams PD, Baccarelli AA, Beck S, Bell JT, et al. . DNA methylation aging clocks: challenges and recommendations. Genome Biol. (2019) 20:249. 10.1186/s13059-019-1824-y
    1. Herbstman JB, Wang S, Perera FP, Lederman SA, Vishnevetsky J, Rundle AG, et al. . Predictors and consequences of global DNA methylation in cord blood and at three years. PLoS ONE. (2013) 8:e72824. 10.1371/journal.pone.0072824
    1. Martino DJ, Tulic MK, Gordon L, Hodder M, Richman TR, Metcalfe J, et al. . Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans. Epigenetics. (2011) 6:1085–94. 10.4161/epi.6.9.16401
    1. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. . Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. (2005) 102:10604–9. 10.1073/pnas.0500398102
    1. Tan Q, Heijmans BT, Hjelmborg JVB, Soerensen M, Christensen K, Christiansen L. Epigenetic drift in the aging genome: a ten-year follow-up in an elderly twin cohort. Int J Epidemiol. (2016) 45:1146–58. 10.1093/ije/dyw132
    1. Machin M, Amaral AF, Wielscher M, Rezwan FI, Imboden M, Jarvelin MR, et al. . Systematic review of lung function and COPD with peripheral blood DNA methylation in population based studies. BMC Pulm Med. (2017) 17:54. 10.1186/s12890-017-0397-3
    1. Sood A, Petersen H, Blanchette CM, Meek P, Picchi MA, Belinsky SA, et al. . Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med. (2010) 182:1098–104. 10.1164/rccm.201002-0222OC
    1. Meek PM, Sood A, Petersen H, Belinsky SA, Tesfaigzi Y. Epigenetic change (GATA-4 gene methylation) is associated with health status in chronic obstructive pulmonary disease. Biol Res Nurs. (2015) 17:191–8. 10.1177/1099800414538113
    1. Barnes PJ. Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy. Curr Opin Pharmacol. (2021) 56:68–73. 10.1016/j.coph.2020.11.004
    1. Barnes PJ. Inflammatory endotypes in COPD. Allergy. (2019) 74:1249–56. 10.1111/all.13760
    1. Guiot J, Demarche S, Henket M, Paulus V, Graff S, Schleich F, et al. . Methodology for sputum induction and laboratory processing. J Vis Exp. (2017) 130:56612. 10.3791/56612
    1. Morales-Nebreda L, Misharin AV, Perlman H, Budinger GR. The heterogeneity of lung macrophages in the susceptibility to disease. Eur Respir Rev. (2015) 24:505–9. 10.1183/16000617.0031-2015
    1. Amsellem V, Gary-Bobo G, Marcos E, Maitre B, Chaar V, Validire P, et al. . Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2011) 184:1358–66. 10.1164/rccm.201105-0802OC
    1. Øvrevik J. Oxidative potential versus biological effects: a review on the relevance of cell-free/abiotic assays as predictors of toxicity from airborne particulate matter. Int J Mol Sci. (2019) 20:4772. 10.3390/ijms20194772
    1. Øvrevik J, Refsnes M, Låg M, Holme JA, Schwarze PE. Activation of proinflammatory responses in cells of the airway mucosa by particulate matter: oxidant- and non-oxidant-mediated triggering mechanisms. Biomolecules. (2015) 5:1399–440. 10.3390/biom5031399
    1. Saferali A, Lee J, Sin DD, Rouhani FN, Brantly ML, Sandford AJ. Longer telomere length in COPD patients with alpha1-antitrypsin deficiency independent of lung function. PLoS ONE. (2014) 9:e95600. 10.1371/journal.pone.0095600
    1. Rezwan FI, Imboden M, Amaral AFS, Wielscher M, Jeong A, Triebner K, et al. . Association of adult lung function with accelerated biological aging. Aging. (2020) 12:518–42. 10.18632/aging.102639
    1. Wan ES, Qiu W, Baccarelli A, Carey VJ, Bacherman H, Rennard SI, et al. . Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2012) 186:1248–55. 10.1164/rccm.201207-1280OC
    1. Higham A, Booth G, Lea S, Southworth T, Plumb J, Singh D. The effects of corticosteroids on COPD lung macrophages: a pooled analysis. Respir Res. (2015) 16:98. 10.1186/s12931-015-0260-0
    1. Higham A, Karur P, Jackson N, Cunoosamy DM, Jansson P, Singh D. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells. Int J Chron Obstruct Pulmon Dis. (2018) 13:1279–88. 10.2147/COPD.S159936
    1. Lee EY, Oh SS, White MJ, Eng CS, Elhawary JR, Borrell LN, et al. . Ambient air pollution, asthma drug response, and telomere length in African American youth. J Allergy Clin Immunol. (2019) 144:839–45.e10. 10.1016/j.jaci.2019.06.009
    1. Easter M, Bollenbecker S, Barnes JW, Krick S. Targeting aging pathways in chronic obstructive pulmonary disease. Int J Mol Sci. (2020) 21:6924. 10.3390/ijms21186924
    1. Hosgood HD 3rd, Cawthon R, He X, Chanock S, Lan Q. Lung Cancer. (2009) 66:157–61. 10.1016/j.lungcan.2009.02.005

Source: PubMed

3
Se inscrever